nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—CYP3A4—Thiotepa—sarcoma	0.0381	0.458	CbGbCtD
Olopatadine—S100A2—p73 transcription factor network—WT1—sarcoma	0.0194	0.067	CbGpPWpGaD
Olopatadine—S100A2—seminal vesicle—sarcoma	0.0184	0.0498	CbGeAlD
Olopatadine—S100A2—hematopoietic system—sarcoma	0.0175	0.0473	CbGeAlD
Olopatadine—S100A12—myometrium—sarcoma	0.0164	0.0444	CbGeAlD
Olopatadine—CYP3A4—Mitoxantrone—sarcoma	0.0164	0.197	CbGbCtD
Olopatadine—S100A2—Direct p53 effectors—COL18A1—sarcoma	0.0157	0.0542	CbGpPWpGaD
Olopatadine—S100A1—connective tissue—sarcoma	0.0155	0.042	CbGeAlD
Olopatadine—S100A2—skin of body—sarcoma	0.0152	0.0411	CbGeAlD
Olopatadine—S100A12—hematopoietic system—sarcoma	0.0141	0.0381	CbGeAlD
Olopatadine—S100A1—skin of body—sarcoma	0.014	0.0379	CbGeAlD
Olopatadine—S100B—hematopoietic system—sarcoma	0.0139	0.0376	CbGeAlD
Olopatadine—S100A13—connective tissue—sarcoma	0.0138	0.0372	CbGeAlD
Olopatadine—S100A12—connective tissue—sarcoma	0.0136	0.0367	CbGeAlD
Olopatadine—S100B—connective tissue—sarcoma	0.0134	0.0362	CbGeAlD
Olopatadine—S100A13—smooth muscle tissue—sarcoma	0.0126	0.034	CbGeAlD
Olopatadine—S100A13—skin of body—sarcoma	0.0124	0.0336	CbGeAlD
Olopatadine—S100A2—lymphoid tissue—sarcoma	0.0123	0.0333	CbGeAlD
Olopatadine—S100A1—cardiac atrium—sarcoma	0.0122	0.0331	CbGeAlD
Olopatadine—S100B—skin of body—sarcoma	0.0121	0.0327	CbGeAlD
Olopatadine—S100A2—tendon—sarcoma	0.0116	0.0313	CbGeAlD
Olopatadine—CYP3A4—Vincristine—sarcoma	0.0113	0.136	CbGbCtD
Olopatadine—S100A1—tendon—sarcoma	0.0107	0.0288	CbGeAlD
Olopatadine—CYP3A4—Etoposide—sarcoma	0.0103	0.124	CbGbCtD
Olopatadine—S100A12—lymphoid tissue—sarcoma	0.00993	0.0268	CbGeAlD
Olopatadine—S100B—lymphoid tissue—sarcoma	0.0098	0.0265	CbGeAlD
Olopatadine—S100A2—testis—sarcoma	0.00959	0.0259	CbGeAlD
Olopatadine—S100A12—bone marrow—sarcoma	0.00904	0.0244	CbGeAlD
Olopatadine—S100A1—testis—sarcoma	0.00883	0.0239	CbGeAlD
Olopatadine—S100A2—Validated transcriptional targets of TAp63 isoforms—MDM2—sarcoma	0.00852	0.0295	CbGpPWpGaD
Olopatadine—S100A13—testis—sarcoma	0.00783	0.0212	CbGeAlD
Olopatadine—S100A12—testis—sarcoma	0.00773	0.0209	CbGeAlD
Olopatadine—S100A13—liver—sarcoma	0.00741	0.02	CbGeAlD
Olopatadine—S100A12—liver—sarcoma	0.00731	0.0198	CbGeAlD
Olopatadine—CYP3A4—Doxorubicin—sarcoma	0.00705	0.0847	CbGbCtD
Olopatadine—S100A1—lymph node—sarcoma	0.0064	0.0173	CbGeAlD
Olopatadine—S100A2—p73 transcription factor network—MDM2—sarcoma	0.00629	0.0217	CbGpPWpGaD
Olopatadine—S100A13—lymph node—sarcoma	0.00568	0.0154	CbGeAlD
Olopatadine—S100A12—lymph node—sarcoma	0.0056	0.0151	CbGeAlD
Olopatadine—S100B—lymph node—sarcoma	0.00553	0.015	CbGeAlD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—ATF1—sarcoma	0.00519	0.0179	CbGpPWpGaD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—ATF1—sarcoma	0.00491	0.017	CbGpPWpGaD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—ATF1—sarcoma	0.00469	0.0162	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—ATF1—sarcoma	0.00465	0.0161	CbGpPWpGaD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—ATF1—sarcoma	0.00456	0.0158	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—MMP2—sarcoma	0.00447	0.0155	CbGpPWpGaD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—ATF1—sarcoma	0.00444	0.0153	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—ATF1—sarcoma	0.00441	0.0152	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—ATF1—sarcoma	0.0044	0.0152	CbGpPWpGaD
Olopatadine—S100A2—p73 transcription factor network—MYC—sarcoma	0.00439	0.0152	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—ATF1—sarcoma	0.00433	0.015	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—ATF1—sarcoma	0.00432	0.0149	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—ATF1—sarcoma	0.00417	0.0144	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—ATF1—sarcoma	0.00415	0.0144	CbGpPWpGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—ATF1—sarcoma	0.00409	0.0142	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—MDM2—sarcoma	0.00398	0.0137	CbGpPWpGaD
Olopatadine—S100B—MyD88-independent cascade—ATF1—sarcoma	0.00393	0.0136	CbGpPWpGaD
Olopatadine—S100A12—Activated TLR4 signalling—ATF1—sarcoma	0.00374	0.0129	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—ATF1—sarcoma	0.00353	0.0122	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—ATF1—sarcoma	0.00351	0.0121	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—JUN—sarcoma	0.00346	0.0119	CbGpPWpGaD
Olopatadine—HRH1—myometrium—sarcoma	0.00332	0.00899	CbGeAlD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—ATF1—sarcoma	0.00332	0.0115	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—ATF1—sarcoma	0.00313	0.0108	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—ATF1—sarcoma	0.00296	0.0102	CbGpPWpGaD
Olopatadine—HRH1—hematopoietic system—sarcoma	0.00285	0.00772	CbGeAlD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—CREB1—sarcoma	0.00281	0.00971	CbGpPWpGaD
Olopatadine—HRH1—connective tissue—sarcoma	0.00275	0.00743	CbGeAlD
Olopatadine—S100A2—Direct p53 effectors—EGFR—sarcoma	0.00272	0.00939	CbGpPWpGaD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—CREB1—sarcoma	0.00266	0.00919	CbGpPWpGaD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—CREB1—sarcoma	0.00254	0.00879	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—CREB1—sarcoma	0.00252	0.00871	CbGpPWpGaD
Olopatadine—HRH1—smooth muscle tissue—sarcoma	0.00251	0.0068	CbGeAlD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—CREB1—sarcoma	0.00247	0.00855	CbGpPWpGaD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—CREB1—sarcoma	0.0024	0.00831	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—CREB1—sarcoma	0.00239	0.00825	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—CREB1—sarcoma	0.00238	0.00823	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—CREB1—sarcoma	0.00235	0.00811	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—CREB1—sarcoma	0.00234	0.00808	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—TP53—sarcoma	0.00228	0.00789	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—CREB1—sarcoma	0.00226	0.0078	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—CREB1—sarcoma	0.00225	0.00778	CbGpPWpGaD
Olopatadine—S100A12—Cytosolic sensors of pathogen-associated DNA—CTNNB1—sarcoma	0.00222	0.00768	CbGpPWpGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—CREB1—sarcoma	0.00222	0.00767	CbGpPWpGaD
Olopatadine—CYP3A4—hematopoietic system—sarcoma	0.00221	0.00597	CbGeAlD
Olopatadine—S100B—MyD88-independent cascade—CREB1—sarcoma	0.00213	0.00736	CbGpPWpGaD
Olopatadine—S100B—Cytosolic sensors of pathogen-associated DNA—CTNNB1—sarcoma	0.0021	0.00726	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—FOXO1—sarcoma	0.00208	0.0072	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—PDGFRB—sarcoma	0.00208	0.00718	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—PDGFRA—sarcoma	0.00205	0.00707	CbGpPWpGaD
Olopatadine—S100A12—Activated TLR4 signalling—CREB1—sarcoma	0.00202	0.007	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—JUN—sarcoma	0.00202	0.00699	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—CREB1—sarcoma	0.00191	0.00662	CbGpPWpGaD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—JUN—sarcoma	0.00191	0.00661	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—CREB1—sarcoma	0.0019	0.00658	CbGpPWpGaD
Olopatadine—HRH1—tendon—sarcoma	0.00189	0.00511	CbGeAlD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—JUN—sarcoma	0.00183	0.00632	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JUN—sarcoma	0.00181	0.00626	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—CREB1—sarcoma	0.0018	0.00622	CbGpPWpGaD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—JUN—sarcoma	0.00178	0.00615	CbGpPWpGaD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—JUN—sarcoma	0.00173	0.00598	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—JUN—sarcoma	0.00172	0.00593	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JUN—sarcoma	0.00171	0.00592	CbGpPWpGaD
Olopatadine—Eye disorder—Thiotepa—sarcoma	0.00171	0.00664	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—CREB1—sarcoma	0.0017	0.00586	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—JUN—sarcoma	0.00169	0.00583	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—JUN—sarcoma	0.00168	0.00581	CbGpPWpGaD
Olopatadine—Stinging—Doxorubicin—sarcoma	0.00168	0.00651	CcSEcCtD
Olopatadine—Immune system disorder—Thiotepa—sarcoma	0.00165	0.00642	CcSEcCtD
Olopatadine—Sinusitis—Mitoxantrone—sarcoma	0.00165	0.00641	CcSEcCtD
Olopatadine—Mediastinal disorder—Thiotepa—sarcoma	0.00165	0.00641	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—JUN—sarcoma	0.00162	0.00561	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—JUN—sarcoma	0.00162	0.00559	CbGpPWpGaD
Olopatadine—Hypoaesthesia—Vincristine—sarcoma	0.00162	0.00627	CcSEcCtD
Olopatadine—Cough increased—Epirubicin—sarcoma	0.0016	0.00623	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—CREB1—sarcoma	0.0016	0.00554	CbGpPWpGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—JUN—sarcoma	0.0016	0.00551	CbGpPWpGaD
Olopatadine—Erythema—Thiotepa—sarcoma	0.00159	0.00619	CcSEcCtD
Olopatadine—Lacrimation increased—Epirubicin—sarcoma	0.00159	0.00618	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—KIT—sarcoma	0.00159	0.00548	CbGpPWpGaD
Olopatadine—Rhinitis—Mitoxantrone—sarcoma	0.00159	0.00615	CcSEcCtD
Olopatadine—Erythema—Dactinomycin—sarcoma	0.00158	0.00614	CcSEcCtD
Olopatadine—Pharyngitis—Mitoxantrone—sarcoma	0.00157	0.00609	CcSEcCtD
Olopatadine—HRH1—testis—sarcoma	0.00156	0.00423	CbGeAlD
Olopatadine—Ulcer—Epirubicin—sarcoma	0.00155	0.00603	CcSEcCtD
Olopatadine—Back pain—Thiotepa—sarcoma	0.00154	0.00598	CcSEcCtD
Olopatadine—S100B—MyD88-independent cascade—JUN—sarcoma	0.00153	0.00529	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—CREB1—sarcoma	0.00151	0.00522	CbGpPWpGaD
Olopatadine—Vision blurred—Thiotepa—sarcoma	0.0015	0.00583	CcSEcCtD
Olopatadine—Cough increased—Doxorubicin—sarcoma	0.00148	0.00576	CcSEcCtD
Olopatadine—Lacrimation increased—Doxorubicin—sarcoma	0.00147	0.00572	CcSEcCtD
Olopatadine—Ill-defined disorder—Dactinomycin—sarcoma	0.00147	0.0057	CcSEcCtD
Olopatadine—Infestation NOS—Etoposide—sarcoma	0.00147	0.00569	CcSEcCtD
Olopatadine—Infestation—Etoposide—sarcoma	0.00147	0.00569	CcSEcCtD
Olopatadine—Mediastinal disorder—Vincristine—sarcoma	0.00146	0.00568	CcSEcCtD
Olopatadine—S100A12—Activated TLR4 signalling—JUN—sarcoma	0.00146	0.00503	CbGpPWpGaD
Olopatadine—Dermatitis contact—Epirubicin—sarcoma	0.00145	0.00563	CcSEcCtD
Olopatadine—Ulcer—Doxorubicin—sarcoma	0.00144	0.00557	CcSEcCtD
Olopatadine—Malaise—Dactinomycin—sarcoma	0.00143	0.00554	CcSEcCtD
Olopatadine—Cough—Thiotepa—sarcoma	0.00139	0.0054	CcSEcCtD
Olopatadine—Erythema—Mitoxantrone—sarcoma	0.00138	0.00534	CcSEcCtD
Olopatadine—S100B—Activated TLR4 signalling—JUN—sarcoma	0.00138	0.00476	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—JUN—sarcoma	0.00137	0.00473	CbGpPWpGaD
Olopatadine—Back pain—Vincristine—sarcoma	0.00137	0.00531	CcSEcCtD
Olopatadine—Dry eye—Epirubicin—sarcoma	0.00136	0.00526	CcSEcCtD
Olopatadine—Dysgeusia—Mitoxantrone—sarcoma	0.00135	0.00523	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00135	0.00523	CcSEcCtD
Olopatadine—Dermatitis contact—Doxorubicin—sarcoma	0.00134	0.00521	CcSEcCtD
Olopatadine—Back pain—Mitoxantrone—sarcoma	0.00133	0.00517	CcSEcCtD
Olopatadine—Discomfort—Dactinomycin—sarcoma	0.00133	0.00517	CcSEcCtD
Olopatadine—Hypoaesthesia—Etoposide—sarcoma	0.00131	0.00508	CcSEcCtD
Olopatadine—Vision blurred—Mitoxantrone—sarcoma	0.0013	0.00504	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—JUN—sarcoma	0.00129	0.00448	CbGpPWpGaD
Olopatadine—Infection—Thiotepa—sarcoma	0.00129	0.00502	CcSEcCtD
Olopatadine—Oedema—Dactinomycin—sarcoma	0.00129	0.00501	CcSEcCtD
Olopatadine—Infection—Dactinomycin—sarcoma	0.00128	0.00498	CcSEcCtD
Olopatadine—Ill-defined disorder—Mitoxantrone—sarcoma	0.00128	0.00496	CcSEcCtD
Olopatadine—Nervous system disorder—Thiotepa—sarcoma	0.00128	0.00495	CcSEcCtD
Olopatadine—Skin disorder—Thiotepa—sarcoma	0.00126	0.0049	CcSEcCtD
Olopatadine—Dry eye—Doxorubicin—sarcoma	0.00125	0.00487	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—MDM2—sarcoma	0.00125	0.00432	CbGpPWpGaD
Olopatadine—Malaise—Mitoxantrone—sarcoma	0.00124	0.00482	CcSEcCtD
Olopatadine—Eye disorder—Etoposide—sarcoma	0.00123	0.00477	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—JUN—sarcoma	0.00122	0.00422	CbGpPWpGaD
Olopatadine—Cough—Mitoxantrone—sarcoma	0.0012	0.00466	CcSEcCtD
Olopatadine—Immune system disorder—Etoposide—sarcoma	0.00119	0.00461	CcSEcCtD
Olopatadine—Mediastinal disorder—Etoposide—sarcoma	0.00119	0.0046	CcSEcCtD
Olopatadine—Eye pain—Epirubicin—sarcoma	0.00118	0.00458	CcSEcCtD
Olopatadine—Discomfort—Mitoxantrone—sarcoma	0.00116	0.00449	CcSEcCtD
Olopatadine—Somnolence—Thiotepa—sarcoma	0.00116	0.00449	CcSEcCtD
Olopatadine—Oedema—Vincristine—sarcoma	0.00115	0.00448	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—JUN—sarcoma	0.00115	0.00399	CbGpPWpGaD
Olopatadine—Infection—Vincristine—sarcoma	0.00115	0.00445	CcSEcCtD
Olopatadine—CYP3A4—liver—sarcoma	0.00114	0.00309	CbGeAlD
Olopatadine—HRH1—lymph node—sarcoma	0.00113	0.00307	CbGeAlD
Olopatadine—Nervous system disorder—Vincristine—sarcoma	0.00113	0.00439	CcSEcCtD
Olopatadine—Oedema—Mitoxantrone—sarcoma	0.00112	0.00436	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00112	0.00436	CcSEcCtD
Olopatadine—Fatigue—Thiotepa—sarcoma	0.00112	0.00435	CcSEcCtD
Olopatadine—Dysgeusia—Etoposide—sarcoma	0.00112	0.00435	CcSEcCtD
Olopatadine—Infection—Mitoxantrone—sarcoma	0.00112	0.00433	CcSEcCtD
Olopatadine—Fatigue—Dactinomycin—sarcoma	0.00111	0.00432	CcSEcCtD
Olopatadine—Pain—Thiotepa—sarcoma	0.00111	0.00432	CcSEcCtD
Olopatadine—Back pain—Etoposide—sarcoma	0.00111	0.0043	CcSEcCtD
Olopatadine—Pain—Dactinomycin—sarcoma	0.0011	0.00429	CcSEcCtD
Olopatadine—Muscle spasms—Etoposide—sarcoma	0.0011	0.00427	CcSEcCtD
Olopatadine—Eye pain—Doxorubicin—sarcoma	0.00109	0.00424	CcSEcCtD
Olopatadine—Skin disorder—Mitoxantrone—sarcoma	0.00109	0.00424	CcSEcCtD
Olopatadine—Feeling abnormal—Thiotepa—sarcoma	0.00107	0.00416	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—PLCG1—sarcoma	0.00107	0.00369	CbGpPWpGaD
Olopatadine—Feeling abnormal—Dactinomycin—sarcoma	0.00106	0.00413	CcSEcCtD
Olopatadine—Gastrointestinal pain—Thiotepa—sarcoma	0.00106	0.00413	CcSEcCtD
Olopatadine—Ill-defined disorder—Etoposide—sarcoma	0.00106	0.00412	CcSEcCtD
Olopatadine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00106	0.0041	CcSEcCtD
Olopatadine—Malaise—Etoposide—sarcoma	0.00103	0.00401	CcSEcCtD
Olopatadine—Body temperature increased—Thiotepa—sarcoma	0.00103	0.00399	CcSEcCtD
Olopatadine—Abdominal pain—Thiotepa—sarcoma	0.00103	0.00399	CcSEcCtD
Olopatadine—Body temperature increased—Dactinomycin—sarcoma	0.00102	0.00396	CcSEcCtD
Olopatadine—Abdominal pain—Dactinomycin—sarcoma	0.00102	0.00396	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—ATF1—sarcoma	0.00101	0.00351	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PLCG1—sarcoma	0.00101	0.00349	CbGpPWpGaD
Olopatadine—Dyspnoea—Mitoxantrone—sarcoma	0.001	0.00389	CcSEcCtD
Olopatadine—Cough—Etoposide—sarcoma	0.000999	0.00388	CcSEcCtD
Olopatadine—Somnolence—Mitoxantrone—sarcoma	0.000999	0.00388	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Vincristine—sarcoma	0.000996	0.00387	CcSEcCtD
Olopatadine—Fatigue—Vincristine—sarcoma	0.000995	0.00386	CcSEcCtD
Olopatadine—Pain—Vincristine—sarcoma	0.000987	0.00383	CcSEcCtD
Olopatadine—Dry skin—Epirubicin—sarcoma	0.000977	0.00379	CcSEcCtD
Olopatadine—Fatigue—Mitoxantrone—sarcoma	0.000969	0.00376	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000968	0.00376	CcSEcCtD
Olopatadine—Discomfort—Etoposide—sarcoma	0.000963	0.00374	CcSEcCtD
Olopatadine—Pain—Mitoxantrone—sarcoma	0.000961	0.00373	CcSEcCtD
Olopatadine—S100B—Innate Immune System—ATF1—sarcoma	0.000959	0.00331	CbGpPWpGaD
Olopatadine—Hypersensitivity—Thiotepa—sarcoma	0.000959	0.00372	CcSEcCtD
Olopatadine—Nasopharyngitis—Epirubicin—sarcoma	0.000953	0.0037	CcSEcCtD
Olopatadine—Hypersensitivity—Dactinomycin—sarcoma	0.000951	0.00369	CcSEcCtD
Olopatadine—Gastrointestinal pain—Vincristine—sarcoma	0.000943	0.00366	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—NRAS—sarcoma	0.000937	0.00324	CbGpPWpGaD
Olopatadine—Asthenia—Thiotepa—sarcoma	0.000934	0.00362	CcSEcCtD
Olopatadine—Infection—Etoposide—sarcoma	0.000929	0.0036	CcSEcCtD
Olopatadine—Asthenia—Dactinomycin—sarcoma	0.000927	0.0036	CcSEcCtD
Olopatadine—Feeling abnormal—Mitoxantrone—sarcoma	0.000926	0.00359	CcSEcCtD
Olopatadine—Influenza—Epirubicin—sarcoma	0.000921	0.00358	CcSEcCtD
Olopatadine—Pruritus—Thiotepa—sarcoma	0.000921	0.00357	CcSEcCtD
Olopatadine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000919	0.00357	CcSEcCtD
Olopatadine—Abdominal pain—Vincristine—sarcoma	0.000912	0.00354	CcSEcCtD
Olopatadine—Body temperature increased—Vincristine—sarcoma	0.000912	0.00354	CcSEcCtD
Olopatadine—Skin disorder—Etoposide—sarcoma	0.000908	0.00352	CcSEcCtD
Olopatadine—Dry skin—Doxorubicin—sarcoma	0.000904	0.00351	CcSEcCtD
Olopatadine—Diarrhoea—Thiotepa—sarcoma	0.00089	0.00345	CcSEcCtD
Olopatadine—Abdominal pain—Mitoxantrone—sarcoma	0.000888	0.00345	CcSEcCtD
Olopatadine—Body temperature increased—Mitoxantrone—sarcoma	0.000888	0.00345	CcSEcCtD
Olopatadine—Diarrhoea—Dactinomycin—sarcoma	0.000884	0.00343	CcSEcCtD
Olopatadine—Nasopharyngitis—Doxorubicin—sarcoma	0.000882	0.00342	CcSEcCtD
Olopatadine—S100A12—Immune System—CD34—sarcoma	0.000879	0.00304	CbGpPWpGaD
Olopatadine—Dizziness—Thiotepa—sarcoma	0.00086	0.00334	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Epirubicin—sarcoma	0.000856	0.00332	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—EGFR—sarcoma	0.000854	0.00295	CbGpPWpGaD
Olopatadine—Influenza—Doxorubicin—sarcoma	0.000852	0.00331	CcSEcCtD
Olopatadine—Hypersensitivity—Vincristine—sarcoma	0.00085	0.0033	CcSEcCtD
Olopatadine—Weight increased—Epirubicin—sarcoma	0.000838	0.00325	CcSEcCtD
Olopatadine—Dyspnoea—Etoposide—sarcoma	0.000833	0.00323	CcSEcCtD
Olopatadine—S100B—Immune System—CD34—sarcoma	0.000831	0.00287	CbGpPWpGaD
Olopatadine—Somnolence—Etoposide—sarcoma	0.000831	0.00322	CcSEcCtD
Olopatadine—Hypersensitivity—Mitoxantrone—sarcoma	0.000828	0.00321	CcSEcCtD
Olopatadine—Asthenia—Vincristine—sarcoma	0.000828	0.00321	CcSEcCtD
Olopatadine—Vomiting—Thiotepa—sarcoma	0.000827	0.00321	CcSEcCtD
Olopatadine—Infestation NOS—Epirubicin—sarcoma	0.000821	0.00319	CcSEcCtD
Olopatadine—Infestation—Epirubicin—sarcoma	0.000821	0.00319	CcSEcCtD
Olopatadine—Vomiting—Dactinomycin—sarcoma	0.000821	0.00319	CcSEcCtD
Olopatadine—Rash—Thiotepa—sarcoma	0.00082	0.00318	CcSEcCtD
Olopatadine—Dermatitis—Thiotepa—sarcoma	0.00082	0.00318	CcSEcCtD
Olopatadine—Headache—Thiotepa—sarcoma	0.000815	0.00316	CcSEcCtD
Olopatadine—Rash—Dactinomycin—sarcoma	0.000814	0.00316	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Etoposide—sarcoma	0.000807	0.00313	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—KRAS—sarcoma	0.000807	0.00279	CbGpPWpGaD
Olopatadine—Asthenia—Mitoxantrone—sarcoma	0.000806	0.00313	CcSEcCtD
Olopatadine—Fatigue—Etoposide—sarcoma	0.000806	0.00313	CcSEcCtD
Olopatadine—Pain—Etoposide—sarcoma	0.000799	0.0031	CcSEcCtD
Olopatadine—Urinary tract infection—Epirubicin—sarcoma	0.000799	0.0031	CcSEcCtD
Olopatadine—Conjunctivitis—Epirubicin—sarcoma	0.000799	0.0031	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000792	0.00307	CcSEcCtD
Olopatadine—Diarrhoea—Vincristine—sarcoma	0.000789	0.00306	CcSEcCtD
Olopatadine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000786	0.00272	CbGpPWpGaD
Olopatadine—Weight increased—Doxorubicin—sarcoma	0.000776	0.00301	CcSEcCtD
Olopatadine—Epistaxis—Epirubicin—sarcoma	0.000775	0.00301	CcSEcCtD
Olopatadine—Nausea—Thiotepa—sarcoma	0.000773	0.003	CcSEcCtD
Olopatadine—Sinusitis—Epirubicin—sarcoma	0.000771	0.00299	CcSEcCtD
Olopatadine—Feeling abnormal—Etoposide—sarcoma	0.00077	0.00299	CcSEcCtD
Olopatadine—Diarrhoea—Mitoxantrone—sarcoma	0.000769	0.00298	CcSEcCtD
Olopatadine—Nausea—Dactinomycin—sarcoma	0.000767	0.00298	CcSEcCtD
Olopatadine—Gastrointestinal pain—Etoposide—sarcoma	0.000764	0.00297	CcSEcCtD
Olopatadine—Dizziness—Vincristine—sarcoma	0.000763	0.00296	CcSEcCtD
Olopatadine—Infestation—Doxorubicin—sarcoma	0.00076	0.00295	CcSEcCtD
Olopatadine—Infestation NOS—Doxorubicin—sarcoma	0.00076	0.00295	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—FOXO1—sarcoma	0.000757	0.00262	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—PDGFRB—sarcoma	0.000756	0.00261	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—PDGFRA—sarcoma	0.000744	0.00257	CbGpPWpGaD
Olopatadine—Rhinitis—Epirubicin—sarcoma	0.000739	0.00287	CcSEcCtD
Olopatadine—Body temperature increased—Etoposide—sarcoma	0.000739	0.00287	CcSEcCtD
Olopatadine—Abdominal pain—Etoposide—sarcoma	0.000739	0.00287	CcSEcCtD
Olopatadine—Conjunctivitis—Doxorubicin—sarcoma	0.000739	0.00287	CcSEcCtD
Olopatadine—Urinary tract infection—Doxorubicin—sarcoma	0.000739	0.00287	CcSEcCtD
Olopatadine—Hypoaesthesia—Epirubicin—sarcoma	0.000734	0.00285	CcSEcCtD
Olopatadine—Vomiting—Vincristine—sarcoma	0.000734	0.00285	CcSEcCtD
Olopatadine—Pharyngitis—Epirubicin—sarcoma	0.000732	0.00284	CcSEcCtD
Olopatadine—Rash—Vincristine—sarcoma	0.000727	0.00282	CcSEcCtD
Olopatadine—Dermatitis—Vincristine—sarcoma	0.000727	0.00282	CcSEcCtD
Olopatadine—Headache—Vincristine—sarcoma	0.000723	0.00281	CcSEcCtD
Olopatadine—Epistaxis—Doxorubicin—sarcoma	0.000717	0.00278	CcSEcCtD
Olopatadine—S100B—Innate Immune System—FOXO1—sarcoma	0.000716	0.00248	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PDGFRB—sarcoma	0.000715	0.00247	CbGpPWpGaD
Olopatadine—Vomiting—Mitoxantrone—sarcoma	0.000714	0.00277	CcSEcCtD
Olopatadine—Sinusitis—Doxorubicin—sarcoma	0.000713	0.00277	CcSEcCtD
Olopatadine—Visual impairment—Epirubicin—sarcoma	0.000711	0.00276	CcSEcCtD
Olopatadine—Rash—Mitoxantrone—sarcoma	0.000708	0.00275	CcSEcCtD
Olopatadine—Dermatitis—Mitoxantrone—sarcoma	0.000708	0.00275	CcSEcCtD
Olopatadine—Headache—Mitoxantrone—sarcoma	0.000704	0.00273	CcSEcCtD
Olopatadine—S100B—Innate Immune System—PDGFRA—sarcoma	0.000704	0.00243	CbGpPWpGaD
Olopatadine—Eye disorder—Epirubicin—sarcoma	0.000689	0.00267	CcSEcCtD
Olopatadine—Hypersensitivity—Etoposide—sarcoma	0.000689	0.00267	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—HRAS—sarcoma	0.000686	0.00237	CbGpPWpGaD
Olopatadine—Nausea—Vincristine—sarcoma	0.000685	0.00266	CcSEcCtD
Olopatadine—Rhinitis—Doxorubicin—sarcoma	0.000684	0.00265	CcSEcCtD
Olopatadine—Hypoaesthesia—Doxorubicin—sarcoma	0.000679	0.00263	CcSEcCtD
Olopatadine—Pharyngitis—Doxorubicin—sarcoma	0.000677	0.00263	CcSEcCtD
Olopatadine—Asthenia—Etoposide—sarcoma	0.000671	0.0026	CcSEcCtD
Olopatadine—Nausea—Mitoxantrone—sarcoma	0.000667	0.00259	CcSEcCtD
Olopatadine—Immune system disorder—Epirubicin—sarcoma	0.000666	0.00258	CcSEcCtD
Olopatadine—Mediastinal disorder—Epirubicin—sarcoma	0.000665	0.00258	CcSEcCtD
Olopatadine—Pruritus—Etoposide—sarcoma	0.000661	0.00257	CcSEcCtD
Olopatadine—Visual impairment—Doxorubicin—sarcoma	0.000658	0.00255	CcSEcCtD
Olopatadine—Erythema—Epirubicin—sarcoma	0.000642	0.00249	CcSEcCtD
Olopatadine—Diarrhoea—Etoposide—sarcoma	0.00064	0.00248	CcSEcCtD
Olopatadine—Eye disorder—Doxorubicin—sarcoma	0.000638	0.00247	CcSEcCtD
Olopatadine—S100A12—Immune System—PTPRC—sarcoma	0.000635	0.0022	CbGpPWpGaD
Olopatadine—Dysgeusia—Epirubicin—sarcoma	0.000629	0.00244	CcSEcCtD
Olopatadine—S100A12—Immune System—PLCG1—sarcoma	0.000622	0.00215	CbGpPWpGaD
Olopatadine—Back pain—Epirubicin—sarcoma	0.000621	0.00241	CcSEcCtD
Olopatadine—Dizziness—Etoposide—sarcoma	0.000618	0.0024	CcSEcCtD
Olopatadine—Muscle spasms—Epirubicin—sarcoma	0.000617	0.0024	CcSEcCtD
Olopatadine—Immune system disorder—Doxorubicin—sarcoma	0.000616	0.00239	CcSEcCtD
Olopatadine—Mediastinal disorder—Doxorubicin—sarcoma	0.000615	0.00239	CcSEcCtD
Olopatadine—Vision blurred—Epirubicin—sarcoma	0.000605	0.00235	CcSEcCtD
Olopatadine—S100B—Immune System—PTPRC—sarcoma	0.000601	0.00208	CbGpPWpGaD
Olopatadine—Ill-defined disorder—Epirubicin—sarcoma	0.000596	0.00231	CcSEcCtD
Olopatadine—Vomiting—Etoposide—sarcoma	0.000594	0.00231	CcSEcCtD
Olopatadine—Erythema—Doxorubicin—sarcoma	0.000594	0.00231	CcSEcCtD
Olopatadine—S100A12—Immune System—ATF1—sarcoma	0.000591	0.00204	CbGpPWpGaD
Olopatadine—Rash—Etoposide—sarcoma	0.000589	0.00229	CcSEcCtD
Olopatadine—Dermatitis—Etoposide—sarcoma	0.000589	0.00228	CcSEcCtD
Olopatadine—S100B—Immune System—PLCG1—sarcoma	0.000588	0.00203	CbGpPWpGaD
Olopatadine—Headache—Etoposide—sarcoma	0.000586	0.00227	CcSEcCtD
Olopatadine—Dysgeusia—Doxorubicin—sarcoma	0.000582	0.00226	CcSEcCtD
Olopatadine—Malaise—Epirubicin—sarcoma	0.000579	0.00225	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—KIT—sarcoma	0.000577	0.00199	CbGpPWpGaD
Olopatadine—Back pain—Doxorubicin—sarcoma	0.000575	0.00223	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—TLE1—sarcoma	0.000573	0.00198	CbGpPWpGaD
Olopatadine—Muscle spasms—Doxorubicin—sarcoma	0.000571	0.00222	CcSEcCtD
Olopatadine—Cough—Epirubicin—sarcoma	0.00056	0.00217	CcSEcCtD
Olopatadine—Vision blurred—Doxorubicin—sarcoma	0.00056	0.00217	CcSEcCtD
Olopatadine—S100B—Immune System—ATF1—sarcoma	0.000558	0.00193	CbGpPWpGaD
Olopatadine—Nausea—Etoposide—sarcoma	0.000555	0.00215	CcSEcCtD
Olopatadine—Ill-defined disorder—Doxorubicin—sarcoma	0.000551	0.00214	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—CREB1—sarcoma	0.000549	0.0019	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—KIT—sarcoma	0.000546	0.00189	CbGpPWpGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000543	0.00211	CcSEcCtD
Olopatadine—Discomfort—Epirubicin—sarcoma	0.00054	0.0021	CcSEcCtD
Olopatadine—Malaise—Doxorubicin—sarcoma	0.000536	0.00208	CcSEcCtD
Olopatadine—Dry mouth—Epirubicin—sarcoma	0.000535	0.00207	CcSEcCtD
Olopatadine—Oedema—Epirubicin—sarcoma	0.000524	0.00203	CcSEcCtD
Olopatadine—Infection—Epirubicin—sarcoma	0.000521	0.00202	CcSEcCtD
Olopatadine—S100B—Innate Immune System—CREB1—sarcoma	0.000519	0.0018	CbGpPWpGaD
Olopatadine—Cough—Doxorubicin—sarcoma	0.000518	0.00201	CcSEcCtD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.000516	0.00178	CbGpPWpGaD
Olopatadine—Nervous system disorder—Epirubicin—sarcoma	0.000514	0.00199	CcSEcCtD
Olopatadine—Skin disorder—Epirubicin—sarcoma	0.000509	0.00197	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000502	0.00195	CcSEcCtD
Olopatadine—Discomfort—Doxorubicin—sarcoma	0.0005	0.00194	CcSEcCtD
Olopatadine—Dry mouth—Doxorubicin—sarcoma	0.000495	0.00192	CcSEcCtD
Olopatadine—Oedema—Doxorubicin—sarcoma	0.000485	0.00188	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—VEGFC—sarcoma	0.000484	0.00167	CbGpPWpGaD
Olopatadine—Infection—Doxorubicin—sarcoma	0.000482	0.00187	CcSEcCtD
Olopatadine—Nervous system disorder—Doxorubicin—sarcoma	0.000475	0.00184	CcSEcCtD
Olopatadine—Skin disorder—Doxorubicin—sarcoma	0.000471	0.00183	CcSEcCtD
Olopatadine—Dyspnoea—Epirubicin—sarcoma	0.000467	0.00181	CcSEcCtD
Olopatadine—Somnolence—Epirubicin—sarcoma	0.000466	0.00181	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—MDM2—sarcoma	0.000454	0.00157	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000452	0.00176	CcSEcCtD
Olopatadine—Fatigue—Epirubicin—sarcoma	0.000452	0.00175	CcSEcCtD
Olopatadine—Pain—Epirubicin—sarcoma	0.000448	0.00174	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000442	0.00153	CbGpPWpGaD
Olopatadine—S100A12—Immune System—FOXO1—sarcoma	0.000441	0.00152	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PDGFRB—sarcoma	0.00044	0.00152	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PDGFRA—sarcoma	0.000433	0.0015	CbGpPWpGaD
Olopatadine—Dyspnoea—Doxorubicin—sarcoma	0.000432	0.00168	CcSEcCtD
Olopatadine—Feeling abnormal—Epirubicin—sarcoma	0.000432	0.00168	CcSEcCtD
Olopatadine—Somnolence—Doxorubicin—sarcoma	0.000431	0.00167	CcSEcCtD
Olopatadine—S100B—Innate Immune System—MDM2—sarcoma	0.00043	0.00149	CbGpPWpGaD
Olopatadine—Gastrointestinal pain—Epirubicin—sarcoma	0.000428	0.00166	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000419	0.00162	CcSEcCtD
Olopatadine—Fatigue—Doxorubicin—sarcoma	0.000418	0.00162	CcSEcCtD
Olopatadine—S100B—Immune System—FOXO1—sarcoma	0.000417	0.00144	CbGpPWpGaD
Olopatadine—S100B—Immune System—PDGFRB—sarcoma	0.000416	0.00144	CbGpPWpGaD
Olopatadine—Pain—Doxorubicin—sarcoma	0.000415	0.00161	CcSEcCtD
Olopatadine—Abdominal pain—Epirubicin—sarcoma	0.000414	0.00161	CcSEcCtD
Olopatadine—Body temperature increased—Epirubicin—sarcoma	0.000414	0.00161	CcSEcCtD
Olopatadine—S100B—Immune System—PDGFRA—sarcoma	0.00041	0.00142	CbGpPWpGaD
Olopatadine—Feeling abnormal—Doxorubicin—sarcoma	0.000399	0.00155	CcSEcCtD
Olopatadine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000396	0.00154	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—JUN—sarcoma	0.000395	0.00137	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CTNNB1—sarcoma	0.000392	0.00136	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FLT1—sarcoma	0.000387	0.00134	CbGpPWpGaD
Olopatadine—Hypersensitivity—Epirubicin—sarcoma	0.000386	0.0015	CcSEcCtD
Olopatadine—Body temperature increased—Doxorubicin—sarcoma	0.000383	0.00149	CcSEcCtD
Olopatadine—Abdominal pain—Doxorubicin—sarcoma	0.000383	0.00149	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—PLCG1—sarcoma	0.00038	0.00131	CbGpPWpGaD
Olopatadine—Asthenia—Epirubicin—sarcoma	0.000376	0.00146	CcSEcCtD
Olopatadine—S100B—Innate Immune System—JUN—sarcoma	0.000374	0.00129	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CTNNB1—sarcoma	0.000371	0.00128	CbGpPWpGaD
Olopatadine—Pruritus—Epirubicin—sarcoma	0.000371	0.00144	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—CXCR4—sarcoma	0.000365	0.00126	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ATF1—sarcoma	0.000361	0.00125	CbGpPWpGaD
Olopatadine—Diarrhoea—Epirubicin—sarcoma	0.000358	0.00139	CcSEcCtD
Olopatadine—Hypersensitivity—Doxorubicin—sarcoma	0.000357	0.00139	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—SRC—sarcoma	0.000354	0.00122	CbGpPWpGaD
Olopatadine—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000353	0.00122	CbGpPWpGaD
Olopatadine—Asthenia—Doxorubicin—sarcoma	0.000348	0.00135	CcSEcCtD
Olopatadine—Dizziness—Epirubicin—sarcoma	0.000346	0.00134	CcSEcCtD
Olopatadine—Pruritus—Doxorubicin—sarcoma	0.000343	0.00133	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—NRAS—sarcoma	0.000341	0.00118	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCR4—sarcoma	0.000336	0.00116	CbGpPWpGaD
Olopatadine—S100A12—Immune System—KIT—sarcoma	0.000336	0.00116	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—SRC—sarcoma	0.000335	0.00116	CbGpPWpGaD
Olopatadine—Vomiting—Epirubicin—sarcoma	0.000333	0.00129	CcSEcCtD
Olopatadine—Diarrhoea—Doxorubicin—sarcoma	0.000332	0.00129	CcSEcCtD
Olopatadine—Rash—Epirubicin—sarcoma	0.00033	0.00128	CcSEcCtD
Olopatadine—Dermatitis—Epirubicin—sarcoma	0.00033	0.00128	CcSEcCtD
Olopatadine—Headache—Epirubicin—sarcoma	0.000328	0.00127	CcSEcCtD
Olopatadine—S100B—Innate Immune System—NRAS—sarcoma	0.000322	0.00111	CbGpPWpGaD
Olopatadine—Dizziness—Doxorubicin—sarcoma	0.000321	0.00124	CcSEcCtD
Olopatadine—S100A12—Immune System—CREB1—sarcoma	0.00032	0.00111	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—sarcoma	0.00032	0.0011	CbGpPWpGaD
Olopatadine—S100B—Immune System—KIT—sarcoma	0.000318	0.0011	CbGpPWpGaD
Olopatadine—Nausea—Epirubicin—sarcoma	0.000311	0.00121	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—EGFR—sarcoma	0.000311	0.00107	CbGpPWpGaD
Olopatadine—Vomiting—Doxorubicin—sarcoma	0.000308	0.0012	CcSEcCtD
Olopatadine—Rash—Doxorubicin—sarcoma	0.000306	0.00119	CcSEcCtD
Olopatadine—Dermatitis—Doxorubicin—sarcoma	0.000305	0.00119	CcSEcCtD
Olopatadine—Headache—Doxorubicin—sarcoma	0.000304	0.00118	CcSEcCtD
Olopatadine—S100B—Immune System—CREB1—sarcoma	0.000303	0.00105	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—EGFR—sarcoma	0.000294	0.00102	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—KRAS—sarcoma	0.000293	0.00101	CbGpPWpGaD
Olopatadine—Nausea—Doxorubicin—sarcoma	0.000288	0.00112	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—IGF1R—sarcoma	0.000283	0.000979	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—KRAS—sarcoma	0.000277	0.000959	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FOXO1—sarcoma	0.00027	0.000932	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PDGFRB—sarcoma	0.000269	0.000931	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PDGFRA—sarcoma	0.000265	0.000916	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MDM2—sarcoma	0.000265	0.000915	CbGpPWpGaD
Olopatadine—S100B—Immune System—MDM2—sarcoma	0.00025	0.000865	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—HRAS—sarcoma	0.000249	0.000862	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL2—sarcoma	0.000237	0.000818	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—HRAS—sarcoma	0.000236	0.000815	CbGpPWpGaD
Olopatadine—S100A12—Immune System—JUN—sarcoma	0.00023	0.000795	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CTNNB1—sarcoma	0.000228	0.000789	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL2—sarcoma	0.000224	0.000773	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KDR—sarcoma	0.000223	0.000771	CbGpPWpGaD
Olopatadine—S100B—Immune System—JUN—sarcoma	0.000218	0.000752	CbGpPWpGaD
Olopatadine—S100B—Immune System—CTNNB1—sarcoma	0.000216	0.000746	CbGpPWpGaD
Olopatadine—S100A12—Immune System—SRC—sarcoma	0.000206	0.000713	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KIT—sarcoma	0.000206	0.00071	CbGpPWpGaD
Olopatadine—S100A12—Immune System—NRAS—sarcoma	0.000199	0.000686	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	0.000198	0.000686	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CREB1—sarcoma	0.000196	0.000676	CbGpPWpGaD
Olopatadine—S100B—Immune System—SRC—sarcoma	0.000195	0.000675	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCR4—sarcoma	0.00019	0.000657	CbGpPWpGaD
Olopatadine—S100B—Immune System—NRAS—sarcoma	0.000188	0.000649	CbGpPWpGaD
Olopatadine—S100A12—Immune System—EGFR—sarcoma	0.000181	0.000625	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	0.000181	0.000625	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCR4—sarcoma	0.000173	0.000597	CbGpPWpGaD
Olopatadine—S100B—Immune System—EGFR—sarcoma	0.000171	0.000591	CbGpPWpGaD
Olopatadine—S100A12—Immune System—KRAS—sarcoma	0.000171	0.000591	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	0.000171	0.00059	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MDM2—sarcoma	0.000162	0.000559	CbGpPWpGaD
Olopatadine—S100B—Immune System—KRAS—sarcoma	0.000162	0.000559	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TLE1—sarcoma	0.00016	0.000553	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HRAS—sarcoma	0.000145	0.000502	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	0.000145	0.000502	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL2—sarcoma	0.000145	0.0005	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCND1—sarcoma	0.000141	0.000487	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—JUN—sarcoma	0.000141	0.000486	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CTNNB1—sarcoma	0.00014	0.000483	CbGpPWpGaD
Olopatadine—S100B—Immune System—HRAS—sarcoma	0.000137	0.000475	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFC—sarcoma	0.000135	0.000467	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SRC—sarcoma	0.000126	0.000436	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VEGFA—sarcoma	0.000123	0.000425	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NRAS—sarcoma	0.000121	0.00042	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MYC—sarcoma	0.000113	0.000391	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EGFR—sarcoma	0.000111	0.000382	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FLT1—sarcoma	0.000108	0.000373	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PLCG1—sarcoma	0.000106	0.000367	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KRAS—sarcoma	0.000104	0.000361	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCR4—sarcoma	0.000102	0.000353	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ATF1—sarcoma	0.000101	0.000349	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TP53—sarcoma	9.29e-05	0.000321	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CREB1—sarcoma	9.25e-05	0.00032	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HRAS—sarcoma	8.88e-05	0.000307	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF1R—sarcoma	7.91e-05	0.000274	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FOXO1—sarcoma	7.53e-05	0.00026	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL2—sarcoma	7.53e-05	0.00026	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PDGFRB—sarcoma	7.52e-05	0.00026	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PDGFRA—sarcoma	7.4e-05	0.000256	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL2—sarcoma	6.84e-05	0.000236	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KDR—sarcoma	6.23e-05	0.000215	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ENO2—sarcoma	5.81e-05	0.000201	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HBA1—sarcoma	5.78e-05	0.0002	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KIT—sarcoma	5.74e-05	0.000198	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—NRAS—sarcoma	5.74e-05	0.000198	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CREB1—sarcoma	5.46e-05	0.000189	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—EGFR—sarcoma	5.23e-05	0.000181	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—KRAS—sarcoma	4.94e-05	0.000171	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLCG1—sarcoma	4.93e-05	0.00017	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MDM2—sarcoma	4.52e-05	0.000156	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HRAS—sarcoma	4.2e-05	0.000145	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL2—sarcoma	4.04e-05	0.00014	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCND1—sarcoma	3.94e-05	0.000136	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JUN—sarcoma	3.93e-05	0.000136	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CTNNB1—sarcoma	3.9e-05	0.000135	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SRC—sarcoma	3.52e-05	0.000122	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFA—sarcoma	3.43e-05	0.000119	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NRAS—sarcoma	3.39e-05	0.000117	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MYC—sarcoma	3.16e-05	0.000109	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EGFR—sarcoma	3.09e-05	0.000107	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KRAS—sarcoma	2.92e-05	0.000101	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TP53—sarcoma	2.59e-05	8.96e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HRAS—sarcoma	2.48e-05	8.57e-05	CbGpPWpGaD
